Do patients with Schizophrenia distinguish between attitudes toward antipsychotic medication and pharmacotherapy in general? Validation of the beliefs about medication questionnaire

Journal of Nervous and Mental Disease

Volumn 200, Issue 1, 2012, Pages 33-43

  Beck, Eva Marina ^a   Vögelin, Roman ^a   Wirtz, Markus ^b   Cavelti, Marialuisa ^a   Kvrgic, Sara ^a   Vauth, Roland ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF EDUCATION FREIBURG   (Germany)

Author keywords

attitude; confirmatory factor analysis; medication adherence; psychometric properties; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PSYCHOMETRY; QUESTIONNAIRE; SCHIZOPHRENIA; TEST RETEST RELIABILITY;

ADULT; ATTITUDE TO HEALTH; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84855301577     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0b013e31823e5875     Document Type: Article

References (87)

1. Adams JR, Drake RE, Wolford GL (2007) Shared decision-making preferences of people with severe mental illness. Psychiatr Serv. 58:1219-1221. (Pubitemid 47507963)
2. Addington D, Addington J, Maticka-Tyndale E, Joyce J (1992) Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res. 6:201-208.
3. Aikens JE, Nease DE Jr, Klinkman MS (2008) Explaining patients' beliefs about the necessity and harmfulness of antidepressants. Ann Fam Med. 6:23-29.
4. Aikens JE, Nease DE Jr, Nau DP, Klinkman MS, Schwenk TL (2005) Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med. 3:23-30. (Pubitemid 40203944)
5. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM (1993) Assessment of insight in psychosis. Am J Psychiatry. 150:873-879. (Pubitemid 23156765)
6. Apiquian R, Elena Ulloa R, Herrera-Estrella M, Moreno-Gomez A, Erosa S, Contreras V, Nicolini H, Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C (2009) Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia. Schizophr Res. 112:181-186.
7. Ascher-Svanum H, Faries DE, Zhu B, Ernst FR, Swartz MS, Swanson JW (2006) Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry. 67:453-460.
8. Baumgartner H, Homburg C (1996) Applications of structural equation modeling in marketing and consumer research: A review. Intern J Res Mark. 13:139-160.
9. Beck AT (2008) The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry. 165:969-977.
10. Birchwood M, Smith J, Drury V, Healy J, Macmillan F, Slade M (1994) A self-report Insight Scale for psychosis: Reliability, validity and sensitivity to change. Acta Psychiatr Scand. 89:62-67. (Pubitemid 24028268)
11. Bollen KA (1989) Structural equations with latent variables. New York: Wiley &Sons.
12. Burnham KP, Anderson DR (2003) Model selection and multimodel inference: A practical information-theoretic approach. New York: Springer.
13. Byerly MJ, Nakonezny PA, Rush AJ (2008) The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr Res. 100:60-69.
14. Byrne BM (2001) Structural equation modelling with Amos: Basic concepts, applications, and programming. Mahwah, NJ: Erlbaum.
15. Cattell RB (1966) The screen test for the number of factors. Multivar Behav Res. 1:245-276.
16. Chin WW (1998) The partial least squares approach to structural equation modeling. In: Marcoulides GA (Ed), Modern methods for business research. Mahwah, NJ: Lawrence Erlbaum Associates.
17. Clatworthy J, Bowskill R, Parham R, Rank T, Scott J, Horne R (2008) Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework. J Affect Disord. 116:51-55.
18. Cohen J (1988) Statistical power analysis for the behavioral sciences. New York: Psychology Press.
19. International Test Commission (2010) International Test Commission Guidelines for Translating and Adapting Tests. Available at: http://www.intestcom.org. Accessed on: January 11, 2010.
20. Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika. 16:297-333.
21. Cuesta MJ, Peralta V (1995) Psychopathological dimensions in schizophrenia. Schizophr Bull. 21:473-482.
22. Day JC, Bentall RP, Roberts C, Randall F, Rogers A, Cattell D, Healy D, Rae P, Power C (2005) Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals. Arch Gen Psychiat. 62:717-724. (Pubitemid 41002752)
23. Dolder CR, Lacro JP, Dunn LB, Jeste DV (2002) Antipsychotic medication adherence: Is there a difference between typical and atypical agents? Am J Psychiatry. 159:103-108. (Pubitemid 41070734)
24. First MB, Gibbon M, Spitzer RL, Williams JBW (1996) User's guide for the Structured Clinical Interview for DSM-IV Axis I Disorders - Research Version. New York: Biometrics Research.
25. Fornell C, Larcker DF (1981) Evaluating structural equation models with unobservable variables and measurement errors. JMR. 18:39-49.
26. Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV (2004) Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry. 161:692-699. (Pubitemid 38445514)
27. Gonzalez JS, Penedo FJ, Llabre MM, Duran RE, Antoni MH, Schneiderman N, Horne R (2007) Physical symptoms, beliefs about medications, negative mood, and long-term HIV medication adherence. Ann Behav Med. 34:46-55. (Pubitemid 47481224)
28. Gray R, Leese M, Bindman J, Becker T, Burti L, David A, Gournay K, Kikkert M, Koeter M, Puschner B, Schene A, Thornicroft G, Tansella M (2006) Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br J Psychiatry. 189:508-514. (Pubitemid 44876869)
29. Gray R, White J, Schulz M, Abderhalden C (2010) Enhancing medication adherence in people with schizophrenia: An international programme of research. Int J Ment Health Nurs. 19:36-44.
30. Hair JF, Black WC, Babin BJ, Anderson RE (2009) Multivariate data analysis. Englewood Cliffs, NJ: Prentice Hall.
31. Hall RC (1995) Global assessment of functioning. A modified scale. Psychosomatics. 36:267-275.
32. Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ (2005) Schizophrenia and suicide: Systematic review of risk factors. Br J Psychiatry. 187:9-20. (Pubitemid 41002508)
33. Hildebrandt L, Temme D (2006) Probleme der Validierung mit Strukturgleichungsmodellen. SFB 649 'Economic Risk' Discussion Paper Berlin, Humboldt-Universität. 2006.
34. Hofer A, Fleischhacker WW (2006) Attitudes towards medication in patients with schizophrenia. Acta Psychiatr Scand. 113:161-162. (Pubitemid 43340870)
35. Hogan TP, Awad AG, Eastwood R (1983) A self-report scale predictive of drug compliance in schizophrenics: Reliability and discriminative validity. Psychol Med. 13:177-183. (Pubitemid 13132147)
36. Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC (2002) Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia. J Nerv Ment Dis. 190:597-603.
37. Hons J, Zirko R, Ulrychova M, Cermakova E, Doubek P, Libiger J (2010) Glycine serum level in schizophrenia: Relation to negative symptoms. Psychiatr Res. 176:103-108.
38. Horne R (1997) Representations of medication and treatment: Advances in theory and measurement. In Keith JP, Weinman J (Eds), Perceptions of health and illness: Current research and applications (pp 155-188). Amsterdam, the Netherlands: Harwood Academic Publishers.
39. Horne R (1999) Patients' beliefs about treatment: The hidden determinant of treatment outcome? J Psychosom Res. 47:491-495.
40. Horne R, Weinman J (1999) Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 47:555-567. (Pubitemid 30029305)
41. Horne R, Weinman JA, Hankins M (1999) The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 14:1-25.
42. Hu L, Bentler PM (1998) Fit indices in covariance structure analysis: Sensitivity to underparametrized model misspecification. Psychol Methods. 3:324-353.
43. Hu L, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Modeling. 6:1-55.
44. Hurley AE, Scandura TA, Schriesheim CA, Brannik MT, Seers A, Vandenberg RJ, Williams LJ (1997) Exploratory and confirmatory factor analysis: guidelines, issues, and alternatives. J Organ Behav. 18:667-683. (Pubitemid 127346423)
45. Jackson DL, Gillaspy JA, Purc-Stephenson R (2009) Reporting practices in confirmatory factor analysis: an overview and some recommendations. Psychol Methods. 14:6-23.
46. Janssen B, Gaebel W, Haerter M, Komaharadi F, Lindel B, Weinmann S (2006) Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders. Psychopharmacology. 187:229-236. (Pubitemid 44015617)
47. Jonsdottir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA (2009) Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand. 119:78-84.
48. Kaiser H (1960) The application of electronic computers to factor analysis. Educ Psychol Meas. 20:141-151.
49. Kampman O, Lehtinen K, Lassila V, Leinonen E, Poutanen O, Koivisto A (2000) Attitudes towards neuroleptic treatment: Reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire. Schizophr Res. 45:223-234.
50. Kane JM (2007) Treatment adherence and long-term outcomes. CNS Spectr. 12:21-26.
51. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13:261-276. (Pubitemid 18039085)
52. Kikkert MJ, Schene AH, Koeter MW, Robson D, Born A, Helm H, Nose M, Goss C, Thornicroft G, Gray RJ (2006) Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophr Bull. 32:786-794. (Pubitemid 44412866)
53. Kline RB (2005) Principles and practice of structural equation modelling. New York: Guilford.
54. Kuhner C, Burger C, Keller F, Hautzinger M (2007) Reliability and validity of the Revised Beck Depression Inventory (BDI-II). Results from German samples. Nervenarzt. 78:651-656. (Pubitemid 47365986)
55. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry. 63:892-909. (Pubitemid 35231730)
56. Law MR, Soumerai SB, Ross-Degnan D, Adams AS (2008) A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry. 69:47-53. (Pubitemid 351281996)
57. Leucht S, Kissling W, Davis JM (2009) Second-generation antipsychotics for schizophrenia: Can we resolve the conflict? Psychol Med. 39:1591-1602.
58. Leventhal H, Benyamini Y, Brownlee S, Diefenbach M, Leventhal AE (1997) Illness representations: Theoretical foundations. In Keith JP, Weinman JA (Eds), Perceptions of health and illness: Current research and applications. Amsterdam, the Netherlands: Harwood Academic Publishers.
59. Lobban F, Barrowclough C, Jones S (2005) Assessing cognitive representations of mental health problems. I. The illness perception questionnaire for schizophrenia. Br J Clin Psychol. 44:147-162. (Pubitemid 40873430)
60. Mistler LA, Drake RE (2008) Shared decision making in antipsychotic management. J Psychiatr Pract. 14:333-344.
61. Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA (2009) Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr Bull. 35:336-346.
62. Muller MJ, Marx-Dannigkeit P, Schlosser R, Wetzel H, Addington D, Benkert O (1999) The Calgary Depression Rating Scale for Schizophrenia: Development and interrater reliability of a German version (CDSS-G). J Psychiatr Res. 33:433-443. (Pubitemid 29392692)
63. Naber D (2005) Subjective effects of antipsychotic treatment. Acta Psychiatr Scand. 111:81-83.
64. Nose M, Barbui C, Tansella M (2003) How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med. 33: 1149-1160. (Pubitemid 37265204)
65. O'Donnell C, Donohoe G, Sharkey L, Owens N, Migone M, Harries R, Kinsella A, Larkin C, O'Callaghan E (2003) Compliance therapy: a randomised controlled trial in schizophrenia. BMJ. 327:834.
66. Perkins DO (2002) Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry. 63:1121-1128.
67. Phatak HM, Thomas J 3rd (2006) Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother. 40:1737-1742. (Pubitemid 44544869)
68. Reis HT, Judd CM (2000) Handbook of research methods in social and personality psychology. Cambridge, UK: Cambridge University Press.
69. Rettenbacher MA, Hofer A, Eder U, Hummer M, Kemmler G, Weiss EM, Fleischhacker WW (2004) Compliance in schizophrenia: Psychopathology, side effects, and patients' attitudes toward the illness and medication. J Clin Psychiatry. 65:1211-1218.
70. Rocca P, Crivelli B, Marino F, Mongini T, Portaleone F, Bogetto F (2008) Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia. Compr Psychiatry. 49:170-176. (Pubitemid 351163232)
71. Rousson V, Gasser T, Seifert B (2002) Assessing intrarater, interrater and test-retest reliability of continuous measurements. Stat Med. 21:3431-3446. (Pubitemid 35314660)
72. Rusch N, Todd AR, Bodenhausen GV, Weiden PJ, Corrigan PW (2009) Implicit versus explicit attitudes toward psychiatric medication: Implications for insight and treatment adherence. Schizophr Res. 112:119-122.
73. Sakamoto Y, Ishiguro M, Kitagawa G (1986) Akaike information criterion statistics. New York: Springer.
74. Schriber JBS, Stage FK, King J, Nora A, Barlow EA (2006) Reporting structural equation modeling and confirmatory factor analysis results: A review. J Educ Res. 99:323-337. (Pubitemid 44870325)
75. Shrout PE, Fleiss JL (1979) Intraclass correlations: Uses in assessing rater reliability. Psychol Bull. 86:420-428.
76. Smith GT, McCarthy DM (1995) Methodological considerations in the refinement of clinical instruments. Psychol Assess. 7:300-308.
77. Stieglitz RD, Fähndrich E, Möller H-J (1998) Syndromale Diagnostik Psychischer Störungen. Göttingen, Germany: Hogrefe.
78. Tacchi M-J, Scott J (2005) Improving medication adherence in schizophrenia and bipolar disorders. Chichester, UK: John Wiley & Sons Ltd.
79. Tait L, Birchwood M, Trower P (2002) A new scale (SES) to measure engagement with community mental health services. J Ment Health. 11:191-198. (Pubitemid 34496793)
80. Tait L, Birchwood M, Trower P (2003) Predicting engagement with services for psychosis: Insight, symptoms and recovery style. Br J Psychiatry. 182:123-128. (Pubitemid 36177234)
81. Thompson K, Kulkarni J, Sergejew AA (2000) Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 42:241-247. (Pubitemid 30216535)
82. Tunis SL, Ascher-Svanum H, Stensland M, Kinon BJ (2004) Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs. Pharmacoeconomics. 22:1-8. (Pubitemid 38186956)
83. Watson PW, Garety PA,Weinman J, Dunn G, Bebbington PE, Fowler D, Freeman D, Kuipers E (2006) Emotional dysfunction in schizophrenia spectrum psychosis: The role of illness perceptions. Psychol Med. 36:761-770. (Pubitemid 43744769)
84. Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, Frances A (1994) Rating of medication influences (ROMI) scale in schizophrenia. Schizophr Bull. 20:297-310. (Pubitemid 24171093)
85. Weiden PJ, Kozma C, Grogg A, Locklear J (2004) Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv. 55:886-891. (Pubitemid 39025215)
86. Weir JP (2005) Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res. 19:231-240.
87. Wittchen H-U, Wunderlich U, Gruschwitz S, Zaudig M (1997) Strukturiertes Klinisches Interview für DSM-I. V Achse I: Psychische Störungen. Göttingen, Germany: Hogrefe.